Median Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible, "Median" or the "Company"), manufacturer of eyonis®, a ...

Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and ...

today announced that the Company will present a Late-Breaking scientific poster at the upcoming 2025 American Thoracic Society (ATS) International Conference taking place May 16-21, 2025 ...

LA JOLLA, CA, April 16, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T ...

Interested contributors now have until 19 May 2025 to submit abstracts for the IAEA's International Conference on Emergency Preparedness and Response.

Paper: ‘Glucagon-like peptide-1 receptor agonists compared with bariatric metabolic surgery and the risk of obesity-related cancer: an observational, retrospective cohort study’ by Yael Wolff Sagy et ...

Calluna Pharma AS (Calluna), a clinical stage biotechnology company pioneering first-in-class antibodies to treat inflammatory and fibrotic diseases, today announced that the company will present ...

The deadline to submit abstracts for scientific posters for the IAEA’s International Conference on Radiation Protection in Medicine — X Ray Vision to be hosted in Vienna, Austria from 8 to 12 December ...

Nagpur: Mandar Mule, a research student from Nagpur University's pharmacy department, won the Best Poster Presentation Award ...